Marc Vincenti

Marc Vincenti has a diverse work experience spanning several companies and roles. Marc is currently a Board Member at Skymab Biotherapeutics. Prior to that, they served as the Global Optimization Director - International Business Unit at Pierre Fabre Group. Marc also worked as a Strategic Committee Advisor at CERES BRAIN Therapeutics. Before that, Marc held positions such as Europe Area Director and General Manager at Pierre Fabre Medicament and Pierre Fabre Pharma, respectively. Marc was also the Americas Regional Director at Pierre Fabre Medicament. Additionally, they have held various roles at Pierre Fabre SA, including VP Corporate licensing & Acquisition and Deputy Director Corporate Licensing & Acquisition. Marc started their career at Pierre Fabre M\u00e9dicament as an Oncologie development coordination manager. Prior to that, they worked in regulatory affairs at Pierre Fabre. Marc also had a service militaire experience at CEA - Pharmacology & Immunoanalysis Unit.

Marc Vincenti has a diverse education history. Marc earned a Doctor degree in Pharmacy from Paris-Sud University (Paris XI) between 1984 and 1992. During that time, they also obtained a Master degree in pharmacokinetics from Université Paris Sud (Paris XI) between 1990 and 1991. Additionally, they completed a Master degree in health legislation from Université Paris Sud (Paris XI) in 1993. Later, in 2006, Marc Vincenti attended HEC Paris and received an MBA. Marc also studied general management and pharmaceutical marketing at ESCP Business School, although the dates of this program are not specified.